From Bispecifics to Tetraspecifics: Multiple Targets, One Drug

  • Bi- vs Tri- vs Tetra-specific Antibodies
  • Tri-specifics can physiologically activate T cells and be well tolerated (eg HER2-CD3-CD28)
  • Tetra-specifics can tackle antigen heterogeneity and loss, while physiologically activating T cells